4.1 Article

Sample Sizes Required to Detect Two-Way and Three-Way Interactions Involving Slope Differences in Mixed-Effects Linear Models

Journal

JOURNAL OF BIOPHARMACEUTICAL STATISTICS
Volume 20, Issue 4, Pages 787-802

Publisher

TAYLOR & FRANCIS INC
DOI: 10.1080/10543401003618819

Keywords

Clinical trials; Effect size; Power function; Sample size requirements; Three-way interaction; Two-way interaction

Funding

  1. National Institutes of Health [MH060447, MH066270, DA023021, AI051519]
  2. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051519] Funding Source: NIH RePORTER
  3. NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060447, P30MH066270] Funding Source: NIH RePORTER
  4. NATIONAL INSTITUTE ON DRUG ABUSE [R25DA023021] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Based on maximum likelihood estimates obtained from mixed-effects linear models, closed-form power functions are derived to detect two-way and three-way interactions that involve longitudinal course of outcome over time in clinical trials. Sample size estimates are shown to decrease with increasing within-subject correlations. It is further shown that when clinical trial designs are balanced in group sizes, the sample size required to detect an effect size for a three-way interaction is exactly fourfold that required to detect the same effect size of a two-way interaction. Furthermore, this fourfold relationship virtually holds for unbalanced allocations of subjects if one factor is balanced in the three-way interaction model. Simulations are presented that verify the sample size estimates for two-way and three-way interactions.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available